Clinical Trials Logo

Clinical Trial Summary

The goal of this observational study is to learn about in invasive non-small cell lung cancer patients who underwent pulmonary resection with systematic lymph node dissection from April 2008 to July 2022 . The main question it aims to answer are: determine the situation of zero risk mediastinal lymph metastases and the different lymph node metastatic patterns of tumors with different characteristics. Participants will provide personal information to analyze. and there is not a comparison group.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06161935
Study type Observational
Source Fudan University
Contact
Status Completed
Phase
Start date April 2008
Completion date July 2023

See also
  Status Clinical Trial Phase
Recruiting NCT04669730 - Baduanjin Exercise on Meridian Energy, Lung Function and Heart Rate Variability in Patients Undergoing Lung Operative. N/A
Recruiting NCT05077709 - IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC Phase 2